BerGenBio ASA (0RU5.L)

NOK 9.0

(-0.03%)

Operating Income Summary of BerGenBio ASA

BerGenBio ASA's latest annual operating income in 2023 was -191.81 Million NOK , up 37.24% from previous year.
BerGenBio ASA's latest quarterly operating income in 2024 Q2 was -51.86 Million NOK , down -24.2% from previous quarter.
BerGenBio ASA reported an annual operating income of -305.63 Million NOK in 2022, up 2.81% from previous year.
BerGenBio ASA reported an annual operating income of -314.46 Million NOK in 2021, down -20.44% from previous year.
BerGenBio ASA reported a quarterly operating income of -51.86 Million NOK for 2024 Q2, down -24.2% from previous quarter.
BerGenBio ASA reported a quarterly operating income of -191.81 Million NOK for 2023 FY, up 37.24% from previous quarter.

Annual Operating Income Chart of BerGenBio ASA (2023 - 2014)

Historical Annual Operating Income of BerGenBio ASA (2023 - 2014)

Year	Operating Income	Operating Income Growth
2023	-191.81 Million NOK	37.24%
2022	-305.63 Million NOK	2.81%
2021	-314.46 Million NOK	-20.44%
2020	-261.09 Million NOK	-27.75%
2019	-204.37 Million NOK	-5.06%
2018	-194.53 Million NOK	-5.9%
2017	-183.7 Million NOK	-39.63%
2016	-131.57 Million NOK	-80.42%
2015	-72.92 Million NOK	-23.97%
2014	-58.82 Million NOK	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	-40.87 Million NOK	6.14%
2024 Q2	-51.86 Million NOK	-24.2%
2023 FY	-191.81 Million NOK	37.24%
2023 Q3	-28.09 Million NOK	41.19%
2023 Q2	-47.76 Million NOK	34.05%
2023 Q1	-72.42 Million NOK	5.21%
2023 Q4	-43.54 Million NOK	-55.02%
2022 Q3	-62.42 Million NOK	29.25%
2022 Q1	-78.56 Million NOK	-16.7%
2022 FY	-305.63 Million NOK	2.81%
2022 Q4	-76.4 Million NOK	-22.39%
2022 Q2	-88.23 Million NOK	-12.31%
2021 Q2	-92.3 Million NOK	-10.65%
2021 FY	-314.46 Million NOK	-20.44%
2021 Q4	-67.32 Million NOK	5.74%
2021 Q3	-71.41 Million NOK	22.63%
2021 Q1	-83.41 Million NOK	-16.15%
2020 Q3	-68.31 Million NOK	-5.56%
2020 Q2	-64.71 Million NOK	-15.08%
2020 Q1	-56.23 Million NOK	4.77%
2020 FY	-261.09 Million NOK	-27.75%
2020 Q4	-71.82 Million NOK	-5.14%
2019 Q3	-47.53 Million NOK	8.52%
2019 FY	-204.37 Million NOK	-5.06%
2019 Q4	-59.05 Million NOK	-24.22%
2019 Q2	-51.96 Million NOK	-13.42%
2019 Q1	-45.81 Million NOK	10.0%
2018 Q2	-50.73 Million NOK	7.39%
2018 Q1	-54.78 Million NOK	-15.3%
2018 FY	-194.53 Million NOK	-5.9%
2018 Q4	-50.9 Million NOK	-33.56%
2018 Q3	-38.11 Million NOK	24.87%
2017 Q2	-33.84 Million NOK	48.55%
2017 Q1	-65.78 Million NOK	-134.68%
2017 FY	-183.7 Million NOK	-39.63%
2017 Q4	-47.51 Million NOK	-29.95%
2017 Q3	-36.56 Million NOK	-8.02%
2016 FY	-131.57 Million NOK	-80.42%
2016 Q4	-28.03 Million NOK	-71.56%
2016 Q3	-16.34 Million NOK	75.41%
2016 Q2	-66.46 Million NOK	0.0%
2015 FY	-72.92 Million NOK	-23.97%
2014 FY	-58.82 Million NOK	0.0%

Peer Operating Income Comparison of BerGenBio ASA

Name	Operating Income	Operating Income Difference
Photocure ASA	27.8 Million NOK	789.823%